Product Introduction:
Lariago 64.5 mg Injection contains Chloroquine Phosphate, a well-known antimalarial medicine used to treat and prevent malaria. It works by eliminating the malaria parasite from the bloodstream, offering quick and effective relief from the symptoms and helping prevent further complications.
Uses:
-
Treatment of uncomplicated malaria
-
Adjunct treatment for severe malaria (as advised by a doctor)
-
Prevention of malaria in high-risk areas (as prescribed)
Benefit:
-
Rapid action against malaria parasite
-
Provides effective treatment through injectable form, ideal for patients unable to take oral medication
-
Reduces fever, chills, and other symptoms associated with malaria
-
Trusted antimalarial therapy under medical supervision
Composition:
-
Chloroquine Phosphate 64.5 mg (equivalent to Chloroquine base)
Side Effect:
-
Nausea
-
Vomiting
-
Headache
-
Blurred vision
-
Pain at injection site
-
Rare allergic reactions or heart rhythm disturbances (seek medical help if severe side effects occur)
Safety Advice:
-
To be administered only by a healthcare professional
-
Inform your doctor if you have heart, liver, or kidney conditions
-
Avoid self-medication
-
Regular monitoring may be required with repeated or long-term use
-
Store in a cool, dry place away from sunlight
